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Introduction
The PTPN22 gene is an important risk factor for human
autoimmunity. Two PTPN22 missense-SNPs, both with
functional influence, the R620W (1858C>T, rs2476601) in
exon 14 and the R263Q (788G>A, rs33996649) in exon 10
have been associated with autoimmune diseases [1-4].
Aim
The aim of this study was to evaluate for the first time the
role of the R263Q PTPN22 polymorphism in ulcerative
colitis (UC) and Crohn’s disease (CD), and re-evaluated
the association of the R620W PTPN22 polymorphism
with both diseases.
Patients and methods
A total of 1,677 UC patients, 1,903 CD patients and 3,107
healthy controls, from an initial case-control set of Span-
ish Caucasian ancestry and two independent sample sets
of European ancestry (Dutch and New Zealand), were
included in the study. Genotyping was performed using
TaqMan SNP assays for the R263Q and R620W PTPN22
polymorphisms. Meta-analysis was performed on 6977
CD, 5695 UC and 9254 controls to test the overall effect
of the minor allele of R620W variant, and on the three
Caucasian cohorts for the R263Q polymorphism.
Results
The PTPN22 263Q loss-of-function variant showed an
initial evidence of a significant association with UC in the
Spanish cohort (p=0.026,OR=0.61,95%CI=0.39-0.95),
which was confirmed in the meta-analysis (p=0.013pooled,
OR=0.69,95%CI=0.51-0.93). In contrast, the 263Q allele
showed no association to CD, (p=0.22pooled,OR=1.16,95%
CI=0.91-1.47). We found in the pooled analysis that the
PTPN22 620W gain-of-function variant was associated
with reduced risk of CD (p=7.4E-06pooled, OR=0.81,95%
CI=0.75-0.89) but not of UC (p=0.88pooled, OR=0.98,95%
CI=0.85-1.15).
Conclusion
Our data suggest that two autoimmunity-associated
polymorphisms of the PTPN22 gene are differentially
associated with CD and UC. The R263Q polymorphism
only associated with UC meanwhile the R620W was sig-
nificantly related with CD. Our findings support the
idea that the two major IBD phenotypes differ in some
genetic components, and also in specific variants within
a single gene, thus suggesting the involvement of differ-
ent immunological mechanisms with a related nature.
Author details
1Instituto de Parasitología y Biomedicina “López-Neyra”, CSIC, Granada, Spain.
2Dept. of Clinical Immunology, Hospital Clínico S. Carlos, Madrid, Spain.
3Dept. of Gastroenterology and Hepatology, University Medical Center
Groningen, Groningen, The Netherlands.
4Dept. of Genetics, University
Medical Center Groningen, Groningen, The Netherlands.
5Dept. of
Gastroenterology, Hospital Virgen de las Nieves, Granada, Spain.
6Dept. of
Gastroenterology, Hospital Clínico San Cecilio, Granada, Spain.
7Dept. of
Gastroenterology, Hospital Central de Asturias, Oviedo, Spain.
8Dept. of
Gastroenterology, Hospital Universitario S. Carlos, Madrid, Spain.
9Dept. of
Immunology, Hospital Puerta del Mar, Cádiz, Spain.
10Dept. of
Gastroenterology, Hospital Virgen de la Victoria, Málaga, Spain.
11Dept. of
Immunology, Hospital Virgen de las Nieves, Granada, Spain.
12Division of Cell
Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA.
13Dept. of Medicine, University of Otago, Christchurch, New Zealand.
14Dept.
of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
15Dept. of Gastroenterology, VU University Medical Center, Amsterdam, The
Netherlands.
16Dept. of Gastroenterology and Hepatology, Academic Medical
Center Amsterdam, The Netherlands.
17Dept. of Medicine, University of
1Instituto de Parasitología y Biomedicina “López-Neyra”, CSIC, Granada, Spain
Full list of author information is available at the end of the article
Diaz-Gallo et al. Journal of Translational Medicine 2010, 8(Suppl 1):P2
http://www.translational-medicine.com/content/8/S1/P2
© 2010 Diaz-Gallo et al; licensee BioMed Central Ltd.Otago, Christchurch, New Zealand.
18Biochemistry Dept., University of Otago,
Dunedin, New Zealand.
19Unit of Genetic Epidemiology & Bioinformatics,
Dept. of Epidemiology, University Medical Center Groningen, Groningen, The
Netherlands.
Published: 25 November 2010
References
1. Stanford SM, Mustelin TM, Bottini N: Lymphoid tyrosine phosphatase and
autoimmunity: human genetics rediscovers tyrosine phosphatases. Semin
Immunopathol 2010, 32(2):127-36.
2. Bottini N, et al: A functional variant of lymphoid tyrosine phosphatase is
associated with type I diabetes. Nat Genet 2004, 36(4):337-8.
3. Bottini N, et al: Role of PTPN22 in type 1 diabetes and other
autoimmune diseases. Semin Immunol 2006, 18(4):207-13.
4. Orru V, et al: A loss-of-function variant of PTPN22 is associated with
reduced risk of systemic lupus erythematosus. Hum Mol Genet 2009,
18(3):569-79.
doi:10.1186/1479-5876-8-S1-P2
Cite this article as: Diaz-Gallo et al.: Differential association of two
PTPN22 coding variants with Crohn’s disease and ulcerative colitis.
Journal of Translational Medicine 2010 8(Suppl 1):P2.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Diaz-Gallo et al. Journal of Translational Medicine 2010, 8(Suppl 1):P2
http://www.translational-medicine.com/content/8/S1/P2
Page 2 of 2